Author

Ayane Oba

Observed names: A. Oba, Aonuma, Ayane, Ayane Oba Aonuma

Institutions: Hokkaido University, Hokkaido University Hospital, Sapporo City General Hospital

Observed institutions: Hokkaido University, Hokkaido University Hospital, Sapporo City General Hospital

OpenAlex ID: A5073718992

A Prospective Observational Study on Effect of Short-Term Periodic Steroid Premedication on Bone Metabolism in Gastrointestinal Cancer (ESPRESSO-01)

2017 · Michio Nakamura, Atsushi Ishiguro, et al. · The Oncologist · 48

Incidence of cancer-associated thromboembolism in Japanese gastric and colorectal cancer patients receiving chemotherapy: a single-institutional retrospective cohort analysis (Sapporo CAT study)

2019 · Ayane Oba Aonuma, Michio Nakamura, et al. · BMJ Open · 21

Feasibility of a simplified narrow-band imaging classification system for Barrett’s esophagus for novice endoscopists

2019 · Hiroto Furuhashi, Kenichi Goda, et al. · Journal of Gastroenterology · 4

Phase II study of trastuzumab with irinotecan in HER2-positive metastatic or advanced gastric cancer patients previously treated with trastuzumab and failed: HGCSG 1201/OGSG1205.

2017 · Yasuyuki Kawamoto, Takashi Meguro, et al. · Journal of Clinical Oncology · 2

HGCSG 1201: Phase II study of trastuzumab with irinotecan in HER2-positive metastatic or advanced gastric cancer patients previously treated with trastuzumab

2017 · Takahide Sasaki, Yasuyuki Kawamoto, et al. · Annals of Oncology

543P Thromboembolism in gastrointestinal tract cancer patients receiving chemotherapy: Preplanned analysis of risk factors and survival

2016 · A. Oba, M. Nakamura, et al. · Annals of Oncology

A prospective observational study of the impact on bone metabolism of short-term periodic steroid premedication of chemotherapy for gastrointestinal cancer. (ESPRESSO-01 study): pre-planed subgroup analysis

2016 · M. Nakamura, A. Ishiguro, et al. · Annals of Oncology

P-152 Observational Cohort Study of 1st line Bevacizumab Combined with Chemotherapy in Metastatic Colorectal Cancer (HGCSG0802): Sub-group Analysis by the Glasgow Prognostic Score (GPS)

2016 · T. Miyagishima, S. Yuki, et al. · Annals of Oncology

Update analysis: Thromboembolism in gastrointestinal tract cancer patients receiving chemotherapy.

2016 · Ayane Oba, Michio Nakamura, et al. · Journal of Clinical Oncology

Update analysis: Prospective observational study for the impact of short-term periodic steroid premedication for cancer chemotherapy on bone metabolism—ESPRESSO-01 study.

2016 · Michio Nakamura, Atsushi Ishiguro, et al. · Journal of Clinical Oncology

Prospective observational study for the impact of short-term periodic intravenous steroid premedication for gastrointestinal cancer chemotherapy on bone metabolism.

2016 · Atsushi Ishiguro, Michio Nakamura, et al. · Journal of Clinical Oncology

Updated analysis: Observational cohort study of first-line bevacizumab combined with chemotherapy in metastatic colorectal cancer (HGCSG0802)—Sub-group analysis by KRAS Exon2 status.

2016 · Michio Nakamura, Satoshi Yuki, et al. · Journal of Clinical Oncology

Thromboembolism incidence in patients with gastrointestinal tract cancer receiving chemotherapy: A single-institutional retrospective cohort analysis.

2016 · Ayane Oba, Michio Nakamura, et al. · Journal of Clinical Oncology

Association of morphologic response with progression free survival in patients with metastatic colorectal cancer treated with bevacizumab-based chemotherapy: HGCSG0802.

2015 · Satoshi Yuki, Hiroshi Nakatsumi, et al. · Journal of Clinical Oncology

Works count: 16

Citation count: 76

H-index: 3

I10-index: 2